M&A Deal Summary

Cyberonics Acquires ImThera Medical

On October 5, 2011, Cyberonics acquired medical products company ImThera Medical for 4M USD

Acquisition Highlights
  • This is Cyberonics’ 1st transaction in the Medical Products sector.
  • This is Cyberonics’ largest (disclosed) transaction.
  • This is Cyberonics’ 1st transaction in the United States.
  • This is Cyberonics’ 1st transaction in California.
Investment Fate
  • ImThera Medical was divested to a consortium of strategic buyers in 2017 for 225M USD.

M&A Deal Summary

Date 2011-10-05
Target ImThera Medical
Sector Medical Products
Buyer(s) Cyberonics
Deal Type Add-on Acquisition
Deal Value 4M USD

Target

ImThera Medical

San Diego, California, United States
ImThera Medical, Inc. is a manufacturer of an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, which opens the airway while a patient is sleeping. ImThera Medical was founded in 2004 and is based in San Diego, California.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cyberonics

Houston, Texas, United States

Category Company
Founded 1987
Sector Medical Products
Employees639
Revenue 282M USD (2014)
DESCRIPTION

Cyberonics, Inc. is a medical technology company developer and marketer of VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.


DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-20 cerboMed

Erlangen, Germany

Cerbomed GmbH is an innovative medical device company that focuses on neuromodulation.

Buy $2M